Common variance! [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2012-06-12 22:39 (5129 d 22:14 ago) – Posting: # 8721
Views: 11,241

Hi John!

❝ Could I hypothetically strip the two treatments (successful test formulation and the reference) and re-run stats in a two-way crossover fashion to re-evaulate the data?

(my emphasis)

See this goody (slides 60–67). The title Don’t try this at home! tells it all. You are not the first one having such an idea (see also here).

❝ Would that stand a chance with regulatory?


Close to nil – unless you run sufficiently large simulations demonstrating that the patient’s risk is preserved. Not a trivial job.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
168 visitors (0 registered, 168 guests [including 23 identified bots]).
Forum time: 20:54 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5